These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34997924)

  • 1. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
    Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
    J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.
    Lennartz CS; Pickering JW; Seiler-Mußler S; Bauer L; Untersteller K; Emrich IE; Zawada AM; Radermacher J; Tangri N; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):609-15. PubMed ID: 26787778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
    Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
    J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand.
    Tuntayothin W; Kerr SJ; Boonyakrai C; Udomkarnjananun S; Chukaew S; Sakulbumrungsil R
    Value Health Reg Issues; 2021 May; 24():157-166. PubMed ID: 33662821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
    Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
    JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
    Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic models for chronic kidney disease: a systematic review and external validation.
    van Rijn MHC; van de Luijtgaarden M; van Zuilen AD; Blankestijn PJ; Wetzels JFM; Debray TPA; van den Brand JAJG
    Nephrol Dial Transplant; 2021 Sep; 36(10):1837-1850. PubMed ID: 33051669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic models of diabetic microvascular complications: a systematic review and meta-analysis.
    Saputro SA; Pattanaprateep O; Pattanateepapon A; Karmacharya S; Thakkinstian A
    Syst Rev; 2021 Nov; 10(1):288. PubMed ID: 34724973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK.
    Fraccaro P; van der Veer S; Brown B; Prosperi M; O'Donoghue D; Collins GS; Buchan I; Peek N
    BMC Med; 2016 Jul; 14():104. PubMed ID: 27401013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes.
    Gurudas S; Nugawela M; Prevost AT; Sathish T; Mathur R; Rafferty JM; Blighe K; Rajalakshmi R; Mohan AR; Saravanan J; Majeed A; Mohan V; Owens DR; Robson J; Sivaprasad S;
    Sci Rep; 2021 Jul; 11(1):13654. PubMed ID: 34211028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.
    González-Pérez A; Saéz ME; Vizcaya D; Lind M; García Rodríguez LA
    Prim Care Diabetes; 2020 Aug; 14(4):381-387. PubMed ID: 31791904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow-up registry.
    Kress S; Bramlage P; Holl RW; Möller CD; Mühldorfer S; Reindel J; Seufert J; Landgraf R; Merker L; Meyhöfer SM; Danne T; Fasching P; Mertens PR; Wanner C; Lanzinger S
    Diabetes Obes Metab; 2023 Mar; 25(3):776-784. PubMed ID: 36444743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors.
    Ye W; Ding X; Putnam N; Farej R; Singh R; Wang D; Kuo S; Kong SX; Elliott JC; Lott J; Herman WH
    J Diabetes Complications; 2022 May; 36(5):108180. PubMed ID: 35339377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
    Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
    Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.